TargetAlloMod, a Proprietary Drug Discovery Platform for Immuno-oncology


In partnership with Evotec (2019-Present)

A research collaboration aiming to discover and develop first-in-class therapeutics in oncology with a novel mechanism of action that will deliver highly potent and more durable treatments for immuno-oncology targets.

BACK TO OUR PORTFOLIO